CliffBio
small molecule

ABIRATERONE ACETATE

ABIRATERONE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameABIRATERONE ACETATE
Active ingredientABIRATERONE ACETATE
Strength250MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2018
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.